Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
BioNTech enters CAR-T cell therapy collaboration with Autolus | The ...
Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel ...
Autolus Therapeutics Eyes CAR-T Edge With AUCATZYL Safety, Expands ...
Autolus Competes in CAR-T Frenzy with FDA Approval of Aucatzyl
AGC Biologics to Manufacture LVV for Autolus Therapeutics’ AUCATZYL®
Autolus CAR-T cell therapy gives hope for aggressive blood cancer ...
Autolus - developing CAR T cell therapies for patients with cancer and ...
Autolus Pockets A Massive €68M in Series C for CAR-T Cancer Therapies
NIHR supports Autolus to advance next-generation CAR-T therapies | NIHR
Chimeric Antigen Receptor T Cell therapy | Innovation | Autolus
Autolus - developing CAR T cell therapies for cancer patients
Autolus Therapeutics plc is Pioneering Programmed T cell Therapies
Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy
Autolus secures FDA approval for CAR-T cell therapy use in ALL
Information for patients | Autolus
Autolus Therapeutics’ Aucatzyl Approval: A Breakthrough in CAR T-Cell ...
FDA Approves Autolus CAR-T Therapy for Acute Lymphoblastic Leukemia ...
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy ...
Our CAR T Focus | Autolus
Autolus Therapeutics: Pioneering CAR T-Cell Therapies in Autoimmune ...
Innovation | Autolus
Autolus Therapeutics’ CAR-T therapy gets EU green light - Drug ...
UK’s Autolus Receives RMAT Designation by FDA for CAR T Cell Therapy ...
Next-Generation CAR-T Firm Autolus Raises €130M on NASDAQ IPO
Autolus Therapeutics Presents Positive Results from AUTO4 in Relapsed ...
Autolus outlines path to FDA after CAR-T cell therapy trial hits ...
UK start-up Autolus starts ‘living medicine’ cancer trials | Financial ...
Autolus Therapeutics announces publication describing its small ...
BioNTech's $200 Million Investment in Autolus Marks Milestone in ...
BIOTECH (68) – Autolus Therapeutics Obe-cel as fast-off CD19 CAR-T ...
Autolus Wins FDA Approval for B-ALL CAR T-Cell Therapy Aucatzyl, May ...
BioNTech and Autolus collaborate for CAR T-cell therapies
Autolus (AUTL) Selects Cardinal Health for Cell Therapy Supply
BioNTech, Autolus make wide-ranging licensing, manufacturing deal for ...
CAR T Cell Therapy: Autolus Presents Data on AUT06NG
Autolus Therapeutics: The Story Has Improved (NASDAQ:AUTL) | Seeking Alpha
CAR-T cells and Autolus cell programming | Calira
Autolus Therapeutics Could Hold A Winning CAR T-Cell Ticket (NASDAQ ...
Autolus Raises $220 Million as it Reports Positive Interim Data from ...
Autolus will apply the capital to its CAR T-cell therapy currently ...
Autolus Therapeutics announces a publication in Nature Medicine on obe ...
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene ...
又一款CAR-T疗法，获批 来源：医谷 近日， Autolus Therapeutics （以下简称“Autolus”）公司宣布，其自主研发的 ...
How Does Autolus Therapeutics' Presentation Design Highlight T Cell ...
Autolus Therapeutics to test Cellares Cell Shuttle for obe-cel | AUTL ...
Autolus enters CAR-T race with FDA approval for Aucatzyl
Autolus Therapeutics' AUCATZYL® and Its Potential to Disrupt the CAR T ...
Autolus Therapeutics files BLA for new CAR T cell therapy | Ijlal Syed ...
Autolus - Drug Discovery World (DDW)
Autolus evaluates Cellares automated CAR-T manufacturing platform ...
About us | Autolus
Will they get FDA Approval? A Better Leukemia Treatment - Autolus ...
Autolus Therapeutics Appoints Ryan Richardson to Board of
Autolus Therapeutics announces collaboration with Cabaletta Bio for use ...
Autolus Therapeutics To Present Three Clinical Data Updates On ...
Pipeline products | Innovation | Autolus
Autolus Therapeutics’ Aucatzyl (Obecabtagene Autoleucel) Receives the ...
Autolus Therapeutics presents key data on Obecabtagene Autoleucel (obe ...
Autolus Therapeutics ALL treatment gets FDA orphan drug designation ...
Autolus could treat T-cell lymphoma without leaving the body unprotected
Autolus Therapeutics announces FDA approval of Aucatzyl | The Pharmaletter
CD19/CD5 CAR-T (Autolus Therapeutics Plc)(CD19/CD5 CAR-T (Autolus ...
FDA approves Aucatzyl (obecabtagene autoleucel) for the treatment of ...
BREAKING NEWS: Autolus' CAR-T Cell Therapy Receives FDA Approval: A ...
Updated: FDA approves Autolus’ CAR-T cell therapy for aggressive blood ...
BioNTech and Autolus: CAR-T cell therapy collaboration | Biotech Sphere
Autolus创新CAR-T疗法obe-cel向FDA递交上市申请，治疗B-ALL
AUCATZYL CAR T Therapy Wins EU Approval for Adult Leukemia Treatment ...
3个月内完全缓解！完全缓解率63%！新型CAR-T疗法Aucatzyl获FDA批准，更多癌症患者将受益！ - 知乎
Autolus: CAR-T Therapy Looks Promising (NASDAQ:AUTL) | Seeking Alpha
A Deep Dive into the CAR T Cell Therapy Market Size 2024-2031 Industry ...
Northside Adds New CAR T-cell Therapy for Leukemia - Healthcare and ...
Variety of Connections, Unlimited Licensing Aid Cancer Therapy ...
CAR T-cell therapy in autoimmune diseases - The Lancet
Become a Leader in Oncology | Oncoleader
Obecabtagene Autoleucel (AUCATZYL) Redefines CAR-T Therapy for ALL ...
Frontiers | Advances in Universal CAR-T Cell Therapy
Autolus’s Novel CAR T Therapy Aucatzyl Granted European Marketing ...
Autolus’s cancer-fighting therapy is given $250m backing
Frontiers | Charting new paradigms for CAR-T cell therapy beyond ...
A Review of CAR T-Cell Therapies Approved for the Treatment of Relapsed ...
Sustainable biomanufacturing: Saving lives, without killing the planet ...
Frontiers | Challenges and innovations in CAR-T cell therapy: a ...
CAR T Cell Therapy: A Versatile Living Drug
首个无需REMS的CAR-T疗法获批医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Autolus: MHRA approves commercial CAR-T plant
Frontiers | CAR-T cell therapy for hematological malignancies ...
BioNTech与CAR-T疗法公司Autolus达成合作医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The-Unstoppable-CAR-T-Therapy | Esco Healthcare
NICE backs NHS use of Autolus' leukaemia CAR-T | pharmaphorum
BioNTech's partners and collaborators
01126-1/asset/953d0d8a-28a2-4c22-a384-91d2ef3527e0/main.assets/gr2_lrg.jpg)
